LifeMD Securities Class Action Lawsuit Filed Against Nasdaq Stock

Strategic Insights -

Investors who purchased or acquired LifeMD securities between May 7, 2025, and August 5, 2025, may be eligible for damages due to allegedly false and misleading statements made by the company's executives. Bragar Eagel & Squire, P.C. has announced the filing of a class action lawsuit against LifeMD, Inc. in the United States District Court for the Eastern District of New York. The lawsuit claims that the company's statements regarding its competitive position, 2025 guidance, and customer acquisition costs were materially false and misleading.

Key Takeaways:

  • The lawsuit alleges that LifeMD's executives made false and misleading statements about the company's competitive position, 2025 guidance, and customer acquisition costs.
  • The class period spans from May 7, 2025, to August 5, 2025, and includes all persons and entities who purchased or acquired LifeMD securities during this time.
  • Investors have until October 27, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • The lawsuit claims that investors suffered damages due to the alleged false and misleading statements made by LifeMD's executives.
  • Bragar Eagel & Squire, P.C. is representing the investors and encourages them to contact the firm directly to discuss their options.
  • The lawsuit highlights the importance of transparency and accuracy in corporate reporting and the potential consequences of making false statements to investors.

Statistics:

  • The class period spans 93 days, from May 7, 2025, to August 5, 2025.
  • The lawsuit has been filed in the United States District Court for the Eastern District of New York.
  • Investors have until October 27, 2025, to apply to the Court to be appointed as lead plaintiff.
  • LifeMD's stock price may potentially be affected by the allegations made in the lawsuit.
  • Bragar Eagel & Squire, P.C. has a reputation for representing individual and institutional investors in complex commercial and securities litigation.

Sources:

  • GlobeNewswire, "Bragar Eagel & Squire, P.C. Announces Class Action Lawsuit Against LifeMD, Inc.", October 26, 2025.
  • LifeMD, Inc. (NASDAQ:LFMD) investor report, May 7, 2025 – August 5, 2025.